Dose frequency randomized controlled trial for Dynamic Temporal and Tactile Cueing (DTTC) treatment for childhood apraxia of speech: protocol paper
Open Access
- 25 May 2023
- journal article
- research article
- Published by Springer Nature in BMC Pediatrics
- Vol. 23 (1) , 1-14
Abstract
Background: Childhood apraxia of speech (CAS) is a pediatric motor-based speech sound disorder that requires a specialized approach to intervention. The extant literature on the treatment of CAS commonly recommends intensive treatment using a motor-based approach, with some of the best evidence supporting the use of Dynamic Temporal and Tactile Cueing (DTTC). To date, a rigorous and systematic comparison of high and low dose frequency (i.e., frequency of therapy sessions) has not been undertaken for DTTC, resulting in a lack of evidence to guide decisions about the optimal treatment schedule for this intervention. The current study aims to fill this gap in knowledge by comparing treatment outcomes when dose frequency is varied. Methods: A randomized controlled trial will be conducted to examine the efficacy of low versus high dose frequency on DTTC treatment outcomes in children with CAS. A target of 60 children, 2;6–7;11 years of age, will be recruited to participate in this study. Treatment will be provided in the community setting by speech-language pathologists who have completed specialized training administering DTTC in a research reliable manner. True randomization with concealed allocation will be used to assign children to either the low or high dose frequency group. Treatment will be administered in 1-h sessions either 4 times per week over a 6-week period (high dose) or 2 times per week over a 12-week period (low dose). To measure treatment gains, probe data will be collected before treatment, during treatment, and 1 day, 1 week, 4 weeks, and 12 weeks post-treatment. Probe data will consist of customized treated words and a standard set of untreated words to assess generalization of treatment gains. The primary outcome variable will be whole word accuracy, encompassing segmental, phonotactic, and suprasegmental accuracy. Discussion: This will be the first randomized controlled trial to evaluate dose frequency for DTTC treatment in children with CAS. Trial registration: ClinicalTrials.gov identifier NCT05675306, January 6, 2023.Keywords
All Related Versions
Funding Information
- Once Upon A Time Foundation (75245, 75245, 75245, 75245, 75245, 75245)
This publication has 40 references indexed in Scilit:
- Measuring communicative participation using the FOCUS©: Focus on the Outcomes of Communication Under SixChild: Care, Health and Development, 2013
- Intervention Efficacy and Intensity for Children With Speech Sound DisorderJournal of Speech, Language, and Hearing Research, 2013
- Relationship between speech motor control and speech intelligibility in children with speech sound disordersJournal of Communication Disorders, 2013
- A Motor Speech Assessment for Children With Severe Speech Disorders: Reliability and Validity EvidenceJournal of Speech, Language, and Hearing Research, 2013
- A comparison of two treatments for childhood apraxia of speech: methods and treatment protocol for a parallel group randomised control trialBMC Pediatrics, 2012
- Latent growth curve analysis of fear during a speech task before and after treatment for social phobiaBehaviour Research and Therapy, 2011
- Stability and composition of functional synergies for speech movements in children with developmental speech disordersJournal of Communication Disorders, 2011
- Differential treatment intensity research: A missing link to creating optimally effective communication interventionsMental Retardation and Developmental Disabilities Research Reviews, 2007
- Applications of Individual Growth Curve Modeling for Pediatric Psychology ResearchJournal of Pediatric Psychology, 2005
- Using covariance structure analysis to detect correlates and predictors of individual change over time.Psychological Bulletin, 1994